Back to search

Article

Engineering Functionality Optimized fully human B7-H3 CAR T Cells for Enhanced Solid Tumor Therapy

2026-01-09

Abstract excerpt

<h4>SUMMARY</h4> B7-H3 is a cell surface protein overexpressed in many solid tumors and an attractive target for chimeric antigen receptor (CAR) T cell therapy. The most clinically advanced B7-H3 CARs are derived from murine monoclonal antibodies (mAbs) 376.96 and MGA271, which are now in phase 1/11 trials. However, non-human mAb sequences can provoke immune responses, leading to CAR T-cell rejection and therape...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a7384c83-0b35-57ea-9462-721bf1929e99
DOI
10.64898/2026.01.09.696281
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Engineering Functionality Optimized fully human B7-H3 CAR T Cells for Enhanced Solid Tumor TherapyDOI 10.64898/2026.01.09.696281
Select a neighboring publication to make it the new centre.